SCNX — Stock Film
STOCK FILMSCENE 1/11SCNX · $0.41
Stock Expert AI presents
SCNX
Scienture Holdings, Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Scienture Holdings, Inc. A quick introduction.

On the stock market since 2014, it operates in the world of health and science. It has 9 employees. Now — the numbers.

on the stock market since 2014
9 employees
$6.4M market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $97.

The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.

THE SALES TREND
Sales have been shrinking.

An average decline of 54% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.

$9.9M
2021
$10.3M
2022
$1.4M
2023
$137K
2024
$432K
2025
In the vault right now:
$0
DEBT: $24K
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
17
very weak

Clearly below the class average.

FINANCIAL STRENGTH
9
very weak

Clearly below the class average.

VALUATION
44
weak

Clearly below the class average.

GROWTH
19
very weak

Clearly below the class average.

PRICE MOMENTUM
22
very weak

Clearly below the class average.

WORTH WATCHING

Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.

Business Quality: Profit power and business quality trail similar companies in the sector.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
The stock has lost its spark0/10
Costs eat into the margin4/10
WORTH WATCHING

Cost Efficiency: As sales grow, profit fails to keep the same pace.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 95% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/2
Sales are holding up

The company sells $432K a year; the problem isn’t sales — it’s costs running above that number.

2
THE BRIGHT SIDE · 2/2
Pays a steady dividend

It pays out $9.50 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/3
Small sales, big loss

A loss of $41.5M against $432K in annual sales.

2
THE RISKS · 2/3
Trading under $1

The stock sits at $0.41. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.

3
THE RISKS · 3/3
A wildly swinging price

This stock swings about 3.1 times as much as the market average. Big rallies — and big drops — can both happen fast.

FINALE · THE GRADE
F
0 / 100 · MoonshotScore

On our five-subject report card, SCNX sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: SCNX is a small company that closed last year at a loss. The road back to profit runs through spending discipline.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 24, 2026 · stockexpertai.com · Stock Film